St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for Paul Bae
73.69
-0.58 (-0.78%)
May 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 73.51 - 74.38
52 week 54.80 - 75.73
Open 74.29
Vol / Avg. 1.08M/1.87M
Mkt cap 20.71B
P/E 20.99
Div/yield 0.29/1.57
EPS 3.51
Shares 281.18M
Beta 1.32
Inst. own 86%
Jul 22, 2015
Q2 2015 St. Jude Medical Inc Earnings Release - 9:30AM EDT - Add to calendar
May 12, 2015
St. Jude Medical Inc at Bank of America Merrill Lynch Health Care Conference
May 7, 2015
St. Jude Medical Inc Annual Shareholders Meeting
Apr 22, 2015
Q1 2015 St. Jude Medical Inc Earnings Release
Apr 22, 2015
Q1 2015 St. Jude Medical Inc Earnings Call
Mar 11, 2015
St. Jude Medical Inc at Barclays Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2015
Net profit margin 19.03% 16.99%
Operating margin 24.16% 20.47%
EBITD margin - 31.31%
Return on average assets 10.47% 9.34%
Return on average equity 26.13% 23.77%
Employees 16,000 -
CDP Score - -

Address

1 Saint Jude Medical Dr
SAINT PAUL, MN 55117-1789
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

St. Jude Medical, Inc., is a medical technology company. The Company is engaged in providing solutions for the treatment of epidemic diseases, including atrial fibrillation, heart failure, stroke, coronary artery disease, congenital heart defects, Parkinson’s disease and chronic pain. The Company’s provides medical solutions for Coronary Artery Disease, which offers ILUMIEN system imaging platform; Heart Failure, which offers Quadripolar Pacing, Thoracic Impedance Monitoring, and Left Atrial Pressure Monitoring; Congenital Heart Defects, which offers Ventricular Septal Defect Occlusion, Atrial Septal Defect Occlusion, and Patent Ductus Arteriosus Occlusion; Heart Valve Disease, which offers Surgical Valve Replacement, and Sudden Cardiac Arrest, which offers Implantable Cardiac Defibrillation Therapy. The Company also offers radiofrequency ablation (RFA), spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation therapy solutions for the treatment of chronic pain.

Officers and directors

Daniel J. Starks Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - Americas Division
Age: 47
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 54
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 51
Bio & Compensation  - Reuters
Michael T. Rousseau Chief Operating Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John C. Heinmiller Executive Vice President
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Age: 46
Bio & Compensation  - Reuters
Lisa Malden Andrade Chief Marketing Officer, Vice President
Age: 43
Bio & Compensation  - Reuters
I. Paul Bae Chief Marketing Officer, Vice President - Global Human Resources
Age: 50
Bio & Compensation  - Reuters